AIM2 fosters lung adenocarcinoma immune escape by modulating PD-L1 expression in tumor-associated macrophages via JAK/STAT3
This work was devised to discuss the effect of AIM2 on the immunosuppression of LUAD tumors, as well as its molecular mechanism. An allograft mouse model was built. Mouse macrophages were isolated and collected. The infiltration level of Mø and expression of M1 Mø, M2 Mø markers, and PD-L1 were assa...
Main Authors: | Hua Ye, Wenwen Yu, Yunlei Li, Xiaoqiong Bao, Yangyang Ni, Xiangxiang Chen, Yangjie Sun, Ali Chen, Weilong Zhou, Jifa Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2023.2269790 |
Similar Items
-
JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01) -
An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01) -
JAK/STAT as a Potential Therapeutic Target for Osteolytic Diseases
by: Mariely A. Godoi, et al.
Published: (2023-06-01) -
Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
by: Małgorzata Gałecka, et al.
Published: (2022-04-01) -
The Use of JAK/STAT Inhibitors in Chronic Inflammatory Disorders
by: Giuseppina Caiazzo, et al.
Published: (2023-04-01)